Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Bayer AG is conducting a first-in-human study titled A First-in-human ...
TipRanks on MSN
Bayer’s New Study on Finerenone: A Potential Game-Changer for Pediatric Heart Failure
Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Study Overview: Bayer AG is conducting a Phase 3, single-arm, open-label ...
Lynkuet is the first FDA-approved therapy that blocks both the neurokinin 1 and neurokinin 3 receptors to treat hot flashes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback